HGSI: HUMAN GENOME SCIENCES INC Real-Time Headlines

Ticker

Advertisement

Choose a Broker

Dynamic view of the market

U.S. Markets close in 6 hrs, 17 mins

Symbol	Value	Change	Percentage Change
DJIA	10,230.04	3.10	0.03%
NASDAQ	2,154.30	0.24	0.01%
S&P 500	1,092.35	-0.73	-0.07%

Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Learn More

Get the FREE DailyFinance iPhone application

HUMAN GENOME SCIENCES INC

HGSI

Stock price

28.30 0.00 0.00%

as of 04:00 PM EST on 11/09/2009 in USD (NASDAQ Delay: 15 mins.)
Extended Hours

28.50 0.20 0.71%

as of 09:24 AM EST on 11/10/09

Analyst Consensus

Buy
Analyst Consensus

Strong Buy

Buy

Hold

Sell

Strong Sell
- Add to Portfolio
- Add to Alerts
Discuss: HGSI

HUMAN GENOME SCIENCES INC Real-Time Headlines

Customize
Monday, November 9, 2009

Doc Offers Top Hep C Drug Picks: BioBuzz

11/9/09 | TheStreet.com

Emerging Stock Report Initiates Independent Research Coverage On Human Genome Sciences

11/9/09 | StockWatch

Emerging Stock Report Initiates Independent Research Coverage On Human Genome Sciences

11/9/09 | GlobeNewswire

Thursday, November 5, 2009

Cutting Edge Biotech Companies Human Genome Sciences (HGSI) and Dendreon Corp. (DNDN) Are Poised To Go Higher

11/5/09 View all Related Articles > | Benzinga

Lower Q3 Loss for Human Genome - Analyst Blog

11/5/09 | Zacks Investment Research

Human Genome Sciences And Glaxosmithkline Announce Positive Results In Second Of Two Phase 3 Trials Of Benlysta

11/5/09 | Pharmaceutical Online

Wednesday, November 4, 2009

'Mad Money Lightning Round': Stick With Goldman Sachs

11/4/09 | TheStreet.com

SEC Filing: Insider Buy/Sell

11/4/09 View all Related Articles > | Thomson Financial

This Will Change the Way You Invest

11/4/09 | The Motley Fool

Human Genome Sciences Closed Tuesday At Second Consecutive New High For Year

11/4/09 View all Related Articles > | RTTNews

Tuesday, November 3, 2009

Implied Volatility Alert: NVDA, HGSI

11/3/09 View all Related Articles > | InvestorPlace

10 Stocks Shaking the Market

11/3/09 | The Motley Fool

Goldman Sachs Lifts Tgt on Human Genome Sciences (HGSI) to $30, Sees As Acquisition Candidate

11/3/09 View all Related Articles > | StreetInsider.com

Stocks Advancing Amid Heavy Short Interest - Human Genome Sciences, Sonic Solutions, Vertex Pharmaceuticals Inc, MercadoLibre Inc

11/3/09 View all Related Articles > | Schaeffer's Trading Floor Blog

Human Genome Sciences Set New High For Year Monday

11/3/09 View all Related Articles > | RTTNews

Human Genome target raised to $35 from $25 at JP Morgan

11/3/09 | Theflyonthewall.com

Vanda's Fanapt should reach pharmacy shelves next year, Washington Post says

11/3/09 | Theflyonthewall.com

Monday, November 2, 2009

On The Fly: U.S. Market Wrap-Up for Monday 11/2

11/2/09 | Theflyonthewall.com

Finally Convinced? Benlysta Works!

11/2/09 | The Motley Fool

Today's Big Gainers: Encore Acquistion Company, Human Genome Sciences

11/2/09 | Market News Video

Human Genome CEO says plan is to "remain independent" in CNBC interview

11/2/09 | Theflyonthewall.com

Human Genome CEO says plan is to "remain independent" in CNBC inteview

11/2/09 | Theflyonthewall.com

Barclays & Lazard Capital Upgrade Human Genome Sciences (HGSI)

11/2/09 | StreetInsider.com

Human Genome upgraded to Buy from Hold at Lazard Capital

11/2/09 | Theflyonthewall.com

Human Genome has a bullish pattern in progress on the monthly chart

11/2/09 | Theflyonthewall.com

Human Genome volatility decreases as shares rally 37% on data

11/2/09 | Theflyonthewall.com

Human Genome upgraded to Overweight from Equal Weight at Barclays

11/2/09 | Theflyonthewall.com

Top Day Trader Alerts (CIT, DNDN, F, HGSI, MOT)

11/2/09 View all Related Articles > | 24/7 Wall Street

Biopharma Barrage

11/2/09 | CNBC Video

Leerink Swann Lifts Price Target On Human Genome Sciences (HGSI) to $40

11/2/09 View all Related Articles > | StreetInsider.com

Human Genome target raised to $40 from $30 at Leerink

11/2/09 | Theflyonthewall.com

Biotech Calendar: Key Dates for November

11/2/09 | TheStreet.com

Human Genome Sciences and GlaxoSmithKline Announce Positive Results in Second of Two Phase 3 Trials of BENLYSTA™ in Systemic Lupus Erythematosus

11/2/09 | Business Wire

Human Genome to host conference call

11/2/09 | Theflyonthewall.com

Human Genome and Glaxosmithkline announce positive Phase III Belysta results

11/2/09 | Theflyonthewall.com

Media Digest 11/2/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

11/2/09 | 24/7 Wall Street

Human Genome Sciences and GlaxoSmithKline Announce Positive Results in Second of Two Phase 3 Trials of BENLYSTA™ in Systemic Lupus Erythematosus

11/2/09 | Business Wire

Human Genome Sciences and GlaxoSmithKline Announce Positive Results in Second of Two Phase 3 Trials of BENLYSTA(TM) in Systemic Lupus Erythematosus

11/2/09 | Marketwire

Sunday, November 1, 2009

The Unusual Suspects (BEAT, CIT, CIT-PZ, GNW, GFIG, HGSI, GSK, MCO, BRK-A, RVSN, CSCO)

11/1/09 | 24/7 Wall Street

Friday, October 30, 2009

FDA Panel Seeks ABthrax Data - Analyst Blog

10/30/09 | Zacks Investment Research

1 <Next>
Monday, November 9, 2009

Doc Offers Top Hep C Drug Picks: BioBuzz

11/9/09 | TheStreet.com

Thursday, November 5, 2009

Cutting Edge Biotech Companies Human Genome Sciences (HGSI) and Dendreon Corp. (DNDN) Are Poised To Go Higher

11/5/09 | Benzinga

Lower Q3 Loss for Human Genome - Analyst Blog

11/5/09 | Zacks Investment Research

Wednesday, November 4, 2009

'Mad Money Lightning Round': Stick With Goldman Sachs

11/4/09 | TheStreet.com

SEC Filing: Insider Buy/Sell

11/4/09 View all News Related Articles > | Thomson Financial

This Will Change the Way You Invest

11/4/09 | The Motley Fool

Human Genome Sciences Closed Tuesday At Second Consecutive New High For Year

11/4/09 | RTTNews

Tuesday, November 3, 2009

Implied Volatility Alert: NVDA, HGSI

11/3/09 | InvestorPlace

10 Stocks Shaking the Market

11/3/09 | The Motley Fool

Human Genome Sciences Set New High For Year Monday

11/3/09 View all News Related Articles > | RTTNews

Stocks Advancing Amid Heavy Short Interest - Human Genome Sciences, Sonic Solutions, Vertex Pharmaceuticals Inc, MercadoLibre Inc

11/3/09 | Schaeffer's Investment Research

Human Genome target raised to $35 from $25 at JP Morgan

11/3/09 | Theflyonthewall.com

Vanda's Fanapt should reach pharmacy shelves next year, Washington Post says

11/3/09 | Theflyonthewall.com

Monday, November 2, 2009

Human Genome Sciences (HGSI) - What's Ahead After Positive Lupus Study?

11/2/09 View all News Related Articles > | InvestorPlace

On The Fly: U.S. Market Wrap-Up for Monday 11/2

11/2/09 | Theflyonthewall.com

Finally Convinced? Benlysta Works!

11/2/09 | The Motley Fool

Today's Big Gainers: Encore Acquistion Company, Human Genome Sciences

11/2/09 | Market News Video

Human Genome CEO says plan is to "remain independent" in CNBC interview

11/2/09 | Theflyonthewall.com

Human Genome CEO says plan is to "remain independent" in CNBC inteview

11/2/09 | Theflyonthewall.com

Human Genome upgraded to Buy from Hold at Lazard Capital

11/2/09 | Theflyonthewall.com

Human Genome has a bullish pattern in progress on the monthly chart

11/2/09 | Theflyonthewall.com

Human Genome volatility decreases as shares rally 37% on data

11/2/09 | Theflyonthewall.com

Human Genome upgraded to Overweight from Equal Weight at Barclays

11/2/09 | Theflyonthewall.com

Biopharma Barrage

11/2/09 | CNBC Video

Human Genome target raised to $40 from $30 at Leerink

11/2/09 | Theflyonthewall.com

Biotech Calendar: Key Dates for November

11/2/09 | TheStreet.com

Human Genome to host conference call

11/2/09 | Theflyonthewall.com

Human Genome and Glaxosmithkline announce positive Phase III Belysta results

11/2/09 | Theflyonthewall.com

Friday, October 30, 2009

FDA Panel Seeks ABthrax Data - Analyst Blog

10/30/09 | Zacks Investment Research

Options Update; October 30, 2009

10/30/09 | Theflyonthewall.com

Earnings? Yawn. Trial Data? Moving!

10/30/09 | The Motley Fool

Implied Volatility Alert: HGSI

10/30/09 View all News Related Articles > | InvestorPlace

Human Genome November 20 straddle at $9.50 into data

10/30/09 | Theflyonthewall.com

Human Genome to announce new trial results Monday, analysts optimistic

10/30/09 | Theflyonthewall.com

Human Genome upgraded to Buy from Neutral at Summer Street

10/30/09 | Theflyonthewall.com

Option Skews - Relatively Heavy Call Activity on Citigroup Inc and Human Genome Sciences

10/30/09 | Schaeffer's Investment Research

Biotech Mailbag: The Reason(s) for This Selloff

10/30/09 | TheStreet.com

Thursday, October 29, 2009

Earnings roundup: Callaway Golf, BMC Software

10/29/09 View all News Related Articles > | AP ONLINE

Human Genome reports Q3 EPS (32c) vs. consensus of (31c)

10/29/09 | Theflyonthewall.com

Human Genome files mixed securities shelf under Form S-3ASR

10/29/09 | Theflyonthewall.com

1 <Next>
Monday, November 9, 2009

Emerging Stock Report Initiates Independent Research Coverage On Human Genome Sciences

11/9/09 | StockWatch

Thursday, November 5, 2009

Human Genome Sciences (HGSI) and Dendreon (DNDN) Are Excellent Buys Now

11/5/09 | NASDAQ

Human Genome Sciences And Glaxosmithkline Announce Positive Results In Second Of Two Phase 3 Trials Of Benlysta

11/5/09 | Pharmaceutical Online

Monday, November 2, 2009

Human Genome Sciences, Inc., GlaxoSmithKline Lupus Drug Works in 2nd Trial

11/2/09 View all Trade Related Articles > | Pharm Country

Friday, October 30, 2009

10/30 - News and FDA Updates for Human Genome Sciences (Nasdaq:HGSI), ...

10/30/09 | Pharmacy Choice

Thursday, October 29, 2009

Human Genome Sciences Inc. (HGSI) reports 3rd Quarter ending September 2009 below estimates

10/29/09 | Earnings Whispers

Wednesday, October 28, 2009

US FDA Panel Says More Study on Human Genome Sciences, Inc. Anthrax Drug

10/28/09 View all Trade Related Articles > | Pharm Country

Wednesday, October 21, 2009

Human Genome Sciences gets $75M from Novartis

10/21/09 | Bioscience Technology

Tuesday, October 20, 2009

Human Genome Sciences, Inc., GlaxoSmithKline Report Progress With Lupus Treatment

10/20/09 | Pharm Country

Human Genome Sciences, Inc., GlaxoSmithKline Report Progress With Lupus Treatment

10/20/09 View all Trade Related Articles > | BioSpace

Monday, October 19, 2009

Human Genome Sciences, Inc. to Seek Hepatitis Drug Approval in Q4

10/19/09 View all Trade Related Articles > | Pharm Country

Human Genome Sciences, Inc. to Seek Hepatitis Drug Approval in Q4

10/19/09 | BioSpace

Thursday, October 15, 2009

Human Genome Sciences to Host November 2nd Conference Call to Discuss Top-Line Results from Second Phase 3 Trial of BENLYSTA™ ..

10/15/09 View all Trade Related Articles > | PR-inside - Austria

Wednesday, October 14, 2009

Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Analyst & Investor Meeting

10/14/09 View all Trade Related Articles > | PharmaLive

Thursday, October 1, 2009

Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JMP Securities Conference

10/1/09 | PR-inside - Austria

Thursday, September 17, 2009

Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at UBS Conference

9/17/09 | PR-inside - Austria

Tuesday, September 8, 2009

Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Robert W. Baird Conference

9/8/09 | PharmaLive

Friday, September 4, 2009

09/04 - Novel Evidence-Based Systemic Lupus Erythematosus (SLE) Respon ...

9/4/09 View all Trade Related Articles > | Pharmacy Choice

Human Genome Sciences, Inc.: Journal Reviews Lupus Drug Endpoints Positively

9/4/09 | BioSpace

Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Partners

9/4/09 View all Trade Related Articles > | PR-inside - Austria

Monday, August 17, 2009

Human Genome Sciences, Inc. Achieves Lupus Drug Goals With DSG's EDC

8/17/09 View all Trade Related Articles > | Pharm Country

Tuesday, August 4, 2009

Human Genome Sciences (NASDAQ:HGSI): Upgraded To Buy At ThinkEquity; target raised to $26 (new Street high)

8/4/09 | iStockAnalyst

Monday, August 3, 2009

Human Genome Sciences raises $358M

8/3/09 | Fierce Biotech

Human Genome Sciences Announces Closing of Public Offering

8/3/09 | StockWatch

Wednesday, July 29, 2009

Human Genome Sciences, Inc. To Raise $310M In Stock Offering

7/29/09 View all Trade Related Articles > | BioSpace

Tuesday, July 28, 2009

Human Genome Sciences Announces Pricing of Public Offering of Common Stock

7/28/09 | StockWatch

Wednesday, July 22, 2009

Human Genome Sciences Announces New Order for Raxibacumab (ABthrax(TM)) from U.S. Government

7/22/09 View all Trade Related Articles > | StockWatch

Tuesday, July 21, 2009

ZymoGenetics, Inc. Shares Benefit From Human Genome Sciences, Inc. Trial Success Reported Monday, July 20

7/21/09 View all Trade Related Articles > | BioSpace

Beacon Equity Researches: Diagnostic imaging, Human Genome Sciences, Halliburton, Hasbro and Coca-Cola

7/21/09 | PR-inside - Austria

Monday, July 20, 2009

Reminder - Human Genome Sciences to Host Conference Call to Discuss Top-Line Phase 3 Results for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Systemic Lupus Erythematosus

7/20/09 View all Trade Related Articles > | StockWatch

Friday, July 17, 2009

Odds Stacked Against Human Genome Sciences, Inc.'s Lupus Drug

7/17/09 View all Trade Related Articles > | BioSpace

Thursday, July 9, 2009

Anthrax Drug Could Thwart Terrorists, Human Genome Sciences, Inc.'s Researchers Say

7/9/09 View all Trade Related Articles > | BioSpace

Thursday, July 2, 2009

Human Genome Sciences to Host July 20 Conference Call to Discuss Top-Line Phase 3 Results for Benlysta? (Formerly Lymphostat-B®) in Systemic Lupus Erythematosus

7/2/09 | Biocompare

Wednesday, July 1, 2009

Human Genome Sciences to Host July 20 Conference Call to Discuss Top-Line Phase 3 Results for Benlysta (Formerly Lymphostat-B in Systemic Lupus Erythematosus

7/1/09 | PharmaLive

Wednesday, June 24, 2009

Human Genome Sciences Inc. (NasdaqGM: HGSI) Completes Phase III Trials

6/24/09 | iStockAnalyst

Saturday, June 20, 2009

Human Genome Sciences Announces Completion Of Enrollment In Phase 2b Monthly-Dosing Trial Of Albuferon(R)

6/20/09 View all Trade Related Articles > | Medical News Today - UK

Friday, June 19, 2009

Human Genome Sciences Announces Completion of Enrollment in Phase 2b Monthly-Dosing Trial of Albuferon(R)

6/19/09 View all Trade Related Articles > | StockWatch

Thursday, June 11, 2009

Human Genome Sciences, Inc. Says Lupus Drug Shows Positive Results

6/11/09 View all Trade Related Articles > | BioSpace

Human Genome Sciences Reports Positive Long-Term Data for BENLYSTA (Formerly LymphoStat-B) in Patients With Active Systemic Lupus Erythematosus

6/11/09 View all Trade Related Articles > | PharmaLive

Monday, June 8, 2009

FYI From Human Genome Sciences: GlaxoSmithKline Study Shows GSK's Novel Diabetes Treatment Syncria(R) (Albiglutide) Improves Glucose Control, Reduces Weight

6/8/09 View all Trade Related Articles > | The Pink Sheet Daily

1 <Next>
Monday, November 2, 2009

Human Genome Sciences sees positive results for lupus drug

11/2/09 View all Regional Related Articles > | Washington Business Journal - Washington DC

Friday, October 30, 2009

Human Genome Sciences narrows loss

10/30/09 View all Regional Related Articles > | Washington Business Journal - Washington DC

Tuesday, October 27, 2009

FDA panel want more study of Human Genome Sciences anthrax drug

10/27/09 View all Regional Related Articles > | Washington Business Journal - Washington DC

Tuesday, October 20, 2009

Human Genome Sciences aims for 2010 for lupus drug

10/20/09 | Washington Business Journal - Washington DC

Monday, October 19, 2009

Human Genome Sciences earns $75M milestone payment

10/19/09 | Washington Business Journal - Washington DC

Wednesday, October 14, 2009

Human Genome Sciences Shares Up On Analyst Report

10/14/09 View all Regional Related Articles > | ABC - KMBC-TV - Kansas City MO

Thursday, August 27, 2009

Human Genome Sciences takes hit over rival's test results

8/27/09 | Washington Business Journal - Washington DC

Tuesday, August 25, 2009

Human Genome Sciences: A takeover target?

8/25/09 View all Regional Related Articles > | Washington Business Journal - Washington DC

Wednesday, July 29, 2009

Human Genome Sciences to raise $310M in stock offering

7/29/09 | Baltimore Business Journal - Baltimore MD

Human Genome Sciences to raise $310M in stock offering

7/29/09 | Washington Business Journal - Washington DC

Monday, July 27, 2009

Human Genome Sciences plans stock offering

7/27/09 View all Regional Related Articles > | Washington Business Journal - Washington DC

Wednesday, July 22, 2009

Human Genome Sciences scores second anthrax treatment order

7/22/09 View all Regional Related Articles > | Washington Business Journal - Washington DC

Monday, July 20, 2009

Human Genome Sciences lupus drug met study goal

7/20/09 View all Regional Related Articles > | San Francisco Chronicle - San Francisco CA

Stock Search: Human Genome Sciences, Citi

7/20/09 View all Regional Related Articles > | ABC - KMBC-TV - Kansas City MO

Thursday, July 9, 2009

Human Genome Sciences stock jumps after anthrax drug results

7/9/09 View all Regional Related Articles > | Washington Business Journal - Washington DC

Thursday, June 11, 2009

Human Genome Sciences shares jump on test results

6/11/09 View all Regional Related Articles > | Washington Business Journal - Washington DC

Thursday, May 21, 2009

Human Genome Sciences submits ABthrax to FDA

5/21/09 View all Regional Related Articles > | Baltimore Business Journal - Baltimore MD

Wednesday, April 29, 2009

Human Genome Sciences reports first profit in 10 years

4/29/09 | Washington Business Journal - Washington DC

Monday, April 27, 2009

Human Genome Sciences releases final test results for hepatitis C drug

4/27/09 | Washington Business Journal - Washington DC

Wednesday, March 25, 2009

Morphotek and Human Genome Sciences in development deal

3/25/09 | Philadelphia Business Journal - Philadelphia PA

Thursday, March 12, 2009

Human Genome Sciences execs buy stock at all-time low

3/12/09 | Washington Business Journal - Washington DC

Monday, March 9, 2009

Human Genome Sciences drug succeeds in trial

3/9/09 View all Regional Related Articles > | Washington Business Journal - Washington DC

Thursday, February 26, 2009

Human Genome Sciences losses less severe

2/26/09 | Washington Business Journal - Washington DC

Monday, February 2, 2009

Human Genome Sciences ships anthrax treatment

2/2/09 View all Regional Related Articles > | Washington Business Journal - Washington DC

Friday, August 1, 2008

Human Genome Sciences reports stronger sales, bigger losses

8/1/08 | Washington Business Journal - Washington DC

Wednesday, May 28, 2008

Human Genome Sciences reports progress with late-stage products

5/28/08 | Washington Business Journal - Washington DC

Monday, May 5, 2008

Human Genome Sciences cuts losses, advances clinical studies

5/5/08 View all Regional Related Articles > | Washington Business Journal - Washington DC

Wednesday, April 16, 2008

Human Genome Sciences amends Glaxo drug development deal

4/16/08 | The Boston Globe - Boston MA

Monday, February 25, 2008

Earnings roundup: ONEOK 4Q jumps past Street estimates, Human Genome Sciences 4Q loss widens

2/25/08 | CBS - WJZ 13 - Baltimore MD

Human Genome Sciences reaffirms 2008 outlook for revenue growth on Anthrax treatment contract

2/25/08 | CBS - WJZ 13 - Baltimore MD

Wednesday, January 23, 2008

Human Genome Sciences stock falls on clinical trials setback

1/23/08 View all Regional Related Articles > | Baltimore Business Journal - Baltimore MD

Human Genome Sciences Shares Down On Trial News

1/23/08 | NBC - NBC 4 - Washington DC

Wednesday, January 2, 2008

Human Genome Sciences shares rise on market potential seen in GlaxoSmithKline partnership

1/2/08 View all Regional Related Articles > | CBS - WJZ 13 - Baltimore MD

1 <Next>
Monday, November 9, 2009

Emerging Stock Report Initiates Independent Research Coverage On Human Genome Sciences

11/9/09 | GlobeNewswire

Monday, November 2, 2009

Live Updates:

Ticker

Dynamic view of the market

HUMAN GENOME SCIENCES INC

HGSI

Stock price

Extended Hours

HUMAN GENOME SCIENCES INC Real-Time Headlines

Monday, November 9, 2009

Thursday, November 5, 2009

Wednesday, November 4, 2009

Tuesday, November 3, 2009

Monday, November 2, 2009

Sunday, November 1, 2009

Friday, October 30, 2009

Monday, November 9, 2009

Thursday, November 5, 2009

Wednesday, November 4, 2009

Tuesday, November 3, 2009

Monday, November 2, 2009

Friday, October 30, 2009

Thursday, October 29, 2009

Monday, November 9, 2009

Thursday, November 5, 2009

Monday, November 2, 2009

Friday, October 30, 2009

Thursday, October 29, 2009

Wednesday, October 28, 2009

Wednesday, October 21, 2009

Tuesday, October 20, 2009

Monday, October 19, 2009

Thursday, October 15, 2009

Wednesday, October 14, 2009

Thursday, October 1, 2009

Thursday, September 17, 2009

Tuesday, September 8, 2009

Friday, September 4, 2009

Monday, August 17, 2009

Tuesday, August 4, 2009

Monday, August 3, 2009

Wednesday, July 29, 2009

Tuesday, July 28, 2009

Wednesday, July 22, 2009